| Literature DB >> 1385941 |
S M Wilkinson1, A G Smith, M J Davis, D Mattey, P T Dawes.
Abstract
Sixteen cases of either a pityriasiform or discoid eczematous rash occurring in patients with rheumatoid arthritis receiving treatment with gold (sodium aurothiomalate and auranofin) were studied. The results suggest that this is a dose related, not allergic, reaction to gold. The development of this rash is not an absolute indication to stop treatment with gold. Control can often be effected with potent topical steroids or a reduction in the dose or frequency of treatment with gold.Entities:
Mesh:
Substances:
Year: 1992 PMID: 1385941 PMCID: PMC1004773 DOI: 10.1136/ard.51.7.881
Source DB: PubMed Journal: Ann Rheum Dis ISSN: 0003-4967 Impact factor: 19.103